Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Pharmacotherapeutic treatment strategies for smoking cessation].

Vasic N, Wolf RC, Wolf N, Connemann BJ, Sosic-Vasic Z.

Nervenarzt. 2011 Nov;82(11):1449-59. doi: 10.1007/s00115-010-3203-5. Review. German.

PMID:
21207000
2.

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ.

Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000.

PMID:
21452908
3.
4.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
5.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
6.
7.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
8.
9.

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.

Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO.

Ann Med. 2012 Sep;44(6):588-97. doi: 10.3109/07853890.2012.705016. Epub 2012 Aug 6. Review. Erratum in: Ann Med. 2012 Sep;44(6):597.

PMID:
22860882
10.

Smoking cessation pharmacotherapy.

Frishman WH.

Ther Adv Cardiovasc Dis. 2009 Aug;3(4):287-308. doi: 10.1177/1753944709335754. Epub 2009 Jun 2. Review.

PMID:
19491139
11.

Update on pharmacologic options for smoking cessation treatment.

Nides M.

Am J Med. 2008 Apr;121(4 Suppl 1):S20-31. doi: 10.1016/j.amjmed.2008.01.016. Review.

PMID:
18342163
12.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
13.

Varenicline: for smoking cessation.

Rao J, Shankar PK.

Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):162-4. Review.

PMID:
20071853
14.
15.

Pharmacotherapy for tobacco dependence.

Fant RV, Buchhalter AR, Buchman AC, Henningfield JE.

Handb Exp Pharmacol. 2009;(192):487-510. doi: 10.1007/978-3-540-69248-5_17. Review.

PMID:
19184660
16.
17.

Varenicline: progress in smoking cessation treatment.

Glover ED, Rath JM.

Expert Opin Pharmacother. 2007 Aug;8(11):1757-67. Review.

PMID:
17685891
18.

Smoking cessation intervention: an evidence-based approach.

Laniado-LaborĂ­n R.

Postgrad Med. 2010 Mar;122(2):74-82. doi: 10.3810/pgm.2010.03.2124. Review.

PMID:
20203458
19.

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.

Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.

Arch Intern Med. 2006 Aug 14-28;166(15):1571-7.

PMID:
16908789
20.

New medications for nicotine dependence treatment.

Hurt RD.

Nicotine Tob Res. 1999;1 Suppl 2:S175-9; discussion S207-10. Review.

PMID:
11768177

Supplemental Content

Support Center